Latest Capital Raises News

Dexus (ASX: DXS) reports a statutory net profit of $10.3 million for the half-year ending December 2024, rebounding from a significant loss last year, while navigating challenges from higher interest rates and lower trading profits.

Polymetals Resources Ltd invites eligible shareholders to participate in a new Share Purchase Plan at $0.80 per share, aiming to raise up to $3.2 million after a successful $35 million institutional placement.

Ausmon Resources Limited has launched a Share Purchase Plan aiming to raise up to $540,000 by issuing shares at a discounted price, supporting its exploration and operational funding needs.

Polymetals Resources Ltd has opened a Share Purchase Plan allowing eligible shareholders to invest up to $30,000 each at $0.80 per share, aiming to raise $3.2 million to bolster its balance sheet and fund exploration.

Artemis Resources has completed the second tranche of a $4 million capital raise, enabling the resumption of drilling at its Karratha Gold Project after cyclone-related delays.

Ausmon Resources Limited has announced a Share Purchase Plan offering up to 300 million shares at a discounted price to raise $540,000, aiming to reduce borrowings and fund exploration activities.

HMC Capital Limited has reported a remarkable 680% increase in profit for the half-year ended 31 December 2024, driven by key acquisitions and expansion into digital infrastructure and private credit sectors. The company also announced a fully franked interim dividend, underscoring confidence in its growth trajectory.

Maximus Resources Limited has issued a Target's Statement recommending shareholders accept Astral Resources NL's off-market takeover bid, which offers a significant premium and improved liquidity. The offer, valuing Maximus shares at approximately $0.073 each, aims to consolidate gold assets in Western Australia under Astral's larger portfolio.

Icetana Limited has successfully closed its renounceable pro rata entitlement offer, raising $629,422 through new share issuance, with convertible notes poised to convert into shares shortly.

Neurizon Therapeutics reported a sharp rise in half-year losses to $7.28 million but marked significant progress with its lead drug NUZ-001 entering a major ALS clinical trial and securing critical regulatory designations.

Eagle Mountain Mining has completed a significant capital raise through the issue of over 518 million new shares and 129 million options, including a $3 million loan conversion, bolstering its exploration projects in Arizona.

HiTech Group Australia Limited has reported a robust half-year performance with a 29% increase in net profit and a strategic focus on high-margin ICT services amid growing market demand.